Cost-effectiveness analysis of papillary thyroid cancer surveillance Academic Article uri icon

Overview

MeSH Major

  • Carcinoma
  • Neoplasm Recurrence, Local
  • Thyroid Neoplasms

abstract

  • The cost to detect a recurrence in a low-risk patient is more than 6 and 7 times greater than the cost for intermediate- and high-risk PTC patients. It is difficult to justify this allocation of resources to the surveillance of low-risk patients. Surveillance strategies for the low-risk group should, therefore, be restructured.

publication date

  • December 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4976498

Digital Object Identifier (DOI)

  • 10.1002/cncr.29633

PubMed ID

  • 26280253

Additional Document Info

start page

  • 4132

end page

  • 40

volume

  • 121

number

  • 23